[1]
“Comparative study on efficacy and safety of Rosuvastatin v/s Atorvastatin in patients with metabolic syndrome- a prospective observational study”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 8, no. 3, pp. 326–334, Apr. 2021, doi: 10.61096/ijrpp.v8.iss3.2019.326-334.